Medical Data Vision Co (TSE:3902) Beneish M-Score: -2.92 (As of Aug. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3902 Medical Data Vision Co Ltd TSE:3902
56 GF Score
Price 円1,684.00
GF Value 円657.61
! 7 Warning Signs
View Full Analysis

What is Medical Data Vision Co Beneish M-Score?

Medical Data Vision Co TSE:3902 56 Beneish M-Score is -2.92 as of Aug. 14, 2026. GuruFocus rates TSE:3902 with a GF Score™ of 56/100 and a GF Value™ of 円657.61. The stock has 7 warning signs investors should review.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.92 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Medical Data Vision Co's Beneish M-Score or its related term are showing as below:

TSE:3902' s Beneish M-Score Range Over the Past 10 Years
Min: -3.46   Med: -2.37   Max: -2.22
Current: -2.92

During the past 13 years, the highest Beneish M-Score of Medical Data Vision Co was -2.22. The lowest was -3.46. And the median was -2.37.


Medical Data Vision Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Medical Data Vision Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Data Vision Co Beneish M-Score Chart

Medical Data Vision Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.29 -2.37 -2.87 -2.30 -2.92

Medical Data Vision Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.87 0.00 -2.30 0.00 -2.92

TSE:3902 vs VEEV, TEM, BTSG: Beneish M-Score Comparison

For the Health Information Services subindustry, Medical Data Vision Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medical Data Vision Co Beneish M-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medical Data Vision Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Medical Data Vision Co's Beneish M-Score falls into.


TSE:3902
56GF Score
Medical Data Vision Co Ltd TSE:3902
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Data Vision Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Medical Data Vision Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9873+0.528 * 1.0531+0.404 * 0.8367+0.892 * 1.107+0.115 * 1.1316
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1+4.679 * -0.105048-0.327 * 1.0436
=-2.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was 円1,135 Mil.
Revenue was 円6,539 Mil.
Gross Profit was 円4,553 Mil.
Total Current Assets was 円3,356 Mil.
Total Assets was 円4,778 Mil.
Property, Plant and Equipment(Net PPE) was 円244 Mil.
Depreciation, Depletion and Amortization(DDA) was 円109 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円1,511 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.
Net Income was 円280 Mil.
Gross Profit was 円0 Mil.
Cash Flow from Operations was 円782 Mil.
Total Receivables was 円1,039 Mil.
Revenue was 円5,907 Mil.
Gross Profit was 円4,331 Mil.
Total Current Assets was 円3,111 Mil.
Total Assets was 円4,749 Mil.
Property, Plant and Equipment(Net PPE) was 円238 Mil.
Depreciation, Depletion and Amortization(DDA) was 円128 Mil.
Selling, General, & Admin. Expense(SGA) was 円0 Mil.
Total Current Liabilities was 円1,439 Mil.
Long-Term Debt & Capital Lease Obligation was 円0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1135.156 / 6539.159) / (1038.578 / 5906.958)
=0.173594 / 0.175823
=0.9873

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4331.384 / 5906.958) / (4553.334 / 6539.159)
=0.733268 / 0.696318
=1.0531

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3356.368 + 243.856) / 4778.436) / (1 - (3111.471 + 238.132) / 4749.108)
=0.246569 / 0.294688
=0.8367

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=6539.159 / 5906.958
=1.107

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(127.717 / (127.717 + 238.132)) / (108.788 / (108.788 + 243.856))
=0.349098 / 0.308492
=1.1316

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 6539.159) / (0 / 5906.958)
=0 / 0
=1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0 + 1510.544) / 4778.436) / ((0 + 1438.566) / 4749.108)
=0.316117 / 0.302913
=1.0436

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(280.242 - 0 - 782.205) / 4778.436
=-0.105048

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Medical Data Vision Co has a M-score of -2.92 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.92 mean?
Medical Data Vision Co (TSE:3902) has a Beneish M-Score of -2.92 as of Aug. 14, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medical Data Vision Co and its competitors.
Is Medical Data Vision Co's Beneish M-Score too high?
Medical Data Vision Co's current Beneish M-Score is -2.92. Overall, Medical Data Vision Co has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Medical Data Vision Co's Beneish M-Score compare to VEEV and TEM?
Medical Data Vision Co's Beneish M-Score of -2.92 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Medical Data Vision Co and its competitors. Medical Data Vision Co's current Beneish M-Score is -2.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Data Vision Co stock overvalued right now?
Medical Data Vision Co (TSE:3902) has a current Beneish M-Score of -2.92. The stock's GF Value™ is 円657.61, compared to a current price of 円1,684.00 — trading 156.1% above its estimated fair value. The current Beneish M-Score is -2.92. Medical Data Vision Co's overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Medical Data Vision Co (TSE:3902), the current Beneish M-Score is -2.92 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Data Vision Co (TSE:3902) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Data Vision Co stock appears to be overvalued. The current stock price of 円1,684.00 is trading 156.1% above its estimated GF Value™ of 円657.61.

Key valuation signals for TSE:3902:

  • Beneish M-Score: -2.92
  • GF Value™: 円657.61 vs. price of 円1,684.00 (156.1% above fair value)
  • GF Score™: 56/100 with 7 warning signs

No single metric tells the full story. See the TSE:3902 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medical Data Vision Co Business Description

Address 7, Kandamitoshirocho, Chiyoda-ku, Tokyo, JPN, 101-0053
Medical Data Vision Co Ltd provides health information services. The company is engaged in Development, production, sales, Maintenance work of medical information integration system, Analysis, survey and consulting of various medical data, Planning, design, development, and operation of the portal site. Its products include Calteco that allows patients to store and view a part of clinical information themselves and CADA payment service such as medical expenses postpay service that patients can freely set payment terms. Medical Code is a system that utilizes standard format data such as hospitalized outpatient EF and electronic reception data in DPC format to support solving various management problems and other related products.
56GF Score

Get the complete analysis for TSE:3902

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,684.00
Price
円657.61
GF Value